SCHEMBL2016934

SCHEMBL2016934

S=[C]CC[C]=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696976 0.78
SCHEMBL8173058 0.78
SCHEMBL4330099 0.71
SCHEMBL513946 0.71
SCHEMBL7831243 0.71
SCHEMBL10403087 0.66
SCHEMBL101677 0.66
SCHEMBL4602574 0.66
SCHEMBL15406223 0.59
SCHEMBL10403091 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024114776-A1 BICYCLIC ABASIC NUCLEIC ACID ANALOGS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM 上海舶望制药有限公司 2024-06-06 WO claimed
CN-117500817-A Peptides comprising phosphorylcholine conjugates and methods of synthesizing the same 塔西亚制药公司 2024-02-02 CN claimed
EP-3225627-B9 TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF UNIV NORTHWEST (CN) 2022-01-05 EP claimed
EP-3225627-B1 TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF UNIV NORTHWEST (CN) 2021-11-03 EP claimed
EP-3225627-A1 TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Northwest University (CN) 2017-10-04 EP claimed
US-20170267718-A1 TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF NORTHWEST UNIVERSITY (CN) 2017-09-21 US claimed
US-9522915-B2 Method for preparing an important intermediate of linagliptin 2Y-CHEM, LTD. (CN) 2016-12-20 US claimed
US-20150274728-A1 METHOD FOR PREPARING AN IMPORTANT INTERMEDIATE OF LINAGLIPTIN 2Y-CHEM, LTD. (CN) 2015-10-01 US claimed
US-6815542-B2 Nucleoside compounds and uses thereof RIBAPHARM, INC. 2004-11-09 US claimed
US-20040002596-A1 Nucleoside compounds and uses thereof TECHNOLAS PERFECT VISION GMBH (DE) 2004-01-01 US claimed
EP-1268504-A1 NUCLEOSIDE COMPOUNDS AND USES THEREOF Ribapharm Corp (US) 2003-01-02 EP claimed
US-6495677-B1 1-RIBOFURANOSYL-3-AMIDINO-1,2,4-TRIAZOLE DERIVATIVES; ANTITUMOR AGENTS; AUTOIMMUNE DISEASES; IMMUNOMODULATORS VALEANT SP. Z.O.O. (PL) 2002-12-17 US claimed
WO-2001068663-B1 NUCLEOSIDE COMPOUNDS AND USES THEREOF ICN PHARMACEUTICALS (US) 2002-02-14 WO claimed
WO-2001068663-A1 NUCLEOSIDE COMPOUNDS AND USES THEREOF RIBAPHARM CORP. (US) 2001-09-20 WO claimed
EP-0376218-B1 Racemization free attachment of amino acids to solid phase PERSEPTIVE BIOSYSTEMS INC (US) 1999-02-24 EP claimed
US-5187270-A Solid phase synthesis of peptides using the reaction product of an N-protected amino acid and a 2,4-dichlorophenyl (4-halo methylphenoxy)acetate; efficiency; purity; kinetics MILLIPORE CORPORATION (US) 1993-02-16 US claimed
EP-0376218-A2 Racemization free attachment of amino acids to solid phase PERSEPTIVE BIOSYSTEMS, INC. (US) 1990-07-04 EP claimed
CN-110799520-B Method for synthesizing peptides containing N-substituted amino acids 中外制药株式会社 2024-07-12 CN disclosed
US-4935536-A TRIALKOXYBENZYL PROTECTED AMINO ACID MILLIPORE CORPORATION (US) 1990-06-19 US disclosed
EP-0292228-A2 Protecting groups for asparagine and glutamine in peptide synthesis MILLIPORE CORPORATION (US) 1988-11-23 EP disclosed